Weixi Jiang
Biographic Data
| ID | 7744911 |
|---|---|
| NAME | Weixi Jiang |
| GIVEN NAMES | Weixi |
| FAMILY NAME | Jiang |
| SIGNATURE | JIANG W |
| AFFILIATIONS | Duke Kunshan University |
| ORCID | 0000-0002-5643-6255 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Availability of Hib, Pneumococcal, Rotavirus, and HPV vaccines in China
Vaccines are cornerstones of public health, yet equitable access remains a major global challenge. While China has achieved sustained high coverage of National Immunization Program (NIP) vaccines, some WHO-recommended cost-effective non-NIP vaccines, such as Hib, pneumococcal conjugate (PCV), rotavirus, and human papillomavirus vaccines (HPV) are not universally accessible and often require out-of-pocket payment. This study examines geographic an…
The equity road ahead for financing non-national immunization program vaccines in China
Relying on individual payments as the main financing channel for non-NIP vaccines is unsustainable and inadequate for ensuring universal vaccine access. A concerted and synergistic approach is essential to ensure sufficient, sustainable resources and enhance public financial management to improve equity in the non-NIP vaccines
The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program
TB-DM case detection significantly improved in 2019 after introducing TB-DM co-management activities in Jakarta, while gaps in TB-DM co-management existed between bacteriologically positive and clinically diagnosed TB patients, and across different types of health facilities. Collaboration between TB and DM departments should be strengthened, and more resources need to be mobilized to further improve the co-management of TB-DM in Indonesia
Under-reporting of TB cases and associated factors
This study demonstrates that TB in Eastern China is being underreported. Given that Eastern China is a developed province, one could assume similar problems may be found in other parts of China with fewer resources as well as many low- and middle-income countries. Having an accurate account of the number of national TB cases is essential to understanding the national and global burden of the disease and in managing TB prevention and control effor…
No prominent works on this page.
Under-reporting of TB cases and associated factors
This study demonstrates that TB in Eastern China is being underreported. Given that Eastern China is a developed province, one could assume similar problems may be found in other parts of China with fewer resources as well as many low- and middle-income countries. Having an accurate account of the number of national TB cases is essential to understanding the national and global burden of the disease and in managing TB prevention and control effor…
The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program
TB-DM case detection significantly improved in 2019 after introducing TB-DM co-management activities in Jakarta, while gaps in TB-DM co-management existed between bacteriologically positive and clinically diagnosed TB patients, and across different types of health facilities. Collaboration between TB and DM departments should be strengthened, and more resources need to be mobilized to further improve the co-management of TB-DM in Indonesia
The equity road ahead for financing non-national immunization program vaccines in China
Relying on individual payments as the main financing channel for non-NIP vaccines is unsustainable and inadequate for ensuring universal vaccine access. A concerted and synergistic approach is essential to ensure sufficient, sustainable resources and enhance public financial management to improve equity in the non-NIP vaccines
Availability of Hib, Pneumococcal, Rotavirus, and HPV vaccines in China
Vaccines are cornerstones of public health, yet equitable access remains a major global challenge. While China has achieved sustained high coverage of National Immunization Program (NIP) vaccines, some WHO-recommended cost-effective non-NIP vaccines, such as Hib, pneumococcal conjugate (PCV), rotavirus, and human papillomavirus vaccines (HPV) are not universally accessible and often require out-of-pocket payment. This study examines geographic an…
Medicine (3 works) · Public health (3 works) · Biostatistics (2 works) · China (2 works) · Epidemiology (2 works) · Immunization (2 works) · Nursing (2 works) · Pneumonia and Respiratory Infections (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works)